Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
OPKO HEALTH, INC. terminated 4.50% Convertible Senior Notes due 2025 with certain holders of the Company’s outstanding 4.50% Convertible Senior Notes due 2025 valued at Repurchase and retirement of approximately $144.4 million aggregate principal amount (effective 2024-01-09).
- Action
- termination
- Agreement
- notes offering
- Counterparty
- certain holders of the Company’s outstanding 4.50% Convertible Senior Notes due 2025
- Value
- Repurchase and retirement of approximately $144.4 million aggregate principal amount
- Effective
- 2024-01-09
Exact text from the filing
Also, contemporaneously with the pricing of the 144A Notes, the Company entered into separate, privately negotiated transactions with certain holders of the Company’s outstanding 4.50% Convertible Senior Notes due 2025 to repurchase, on the Closing Date, approximately $144.4 million aggregate principal amount of such notes, all of which notes were retired by the Company upon its acquisition thereof.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
OPKO HEALTH, INC. entered into 144A Note Purchase Agreement and Affiliate Note Purchase Agreement with J.P. Morgan Securities LLC and Affiliate Purchasers (Frost Gamma Investments Trust and Jane H. Hsiao) valued at $301.1 million aggregate principal amount of 3.75% Convertible Senior Notes due 2029 ($230 million 1 (effective 2024-01-09).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- J.P. Morgan Securities LLC and Affiliate Purchasers (Frost Gamma Investments Trust and Jane H. Hsiao)
- Value
- $301.1 million aggregate principal amount of 3.75% Convertible Senior Notes due 2029 ($230 million 1
- Effective
- 2024-01-09
Exact text from the filing
On January 9, 2024 (the “ Closing Date ”), OPKO Health, Inc., a Delaware corporation (the “ Company ”), completed its previously announced private offering of $230.0 million aggregate principal amount of its 3.75% Convertible Senior Notes due 2029 (the “ 144A Notes ”) in accordance with the terms of a note purchase agreement (the “ 144A Note Purchase Agreement ”) entered into on January 4, 2024 by and between by the Company and J.P. Morgan Securities LLC (the “ Initial Purchaser ”). The $230.0 million aggregate principal amount of 144A Notes includes $30.0 million aggregate principal amount of 144A Notes purchased on the Closing Date by the Initial Purchaser in accordance with its exercise in full of its option to purchase additional 144A Notes under the 144A Note Purchase Agreement. Additionally, on the Closing Date, the Company issued and sold approximately $71.1 million aggregate principal amount of its 3.75% Convertible Senior Notes due 2029 (the “ Affiliate Notes ” and, together
View on SEC.gov